United States · 
What does Sanofi-Genzyme BioVentures invest in?
Sanofi-Genzyme BioVentures invests most often at Series B and Series A (64% of the rounds on record), in sectors such as Financial Services, Medical Device and Biopharma.
Sanofi-Genzyme BioVentures highlights
- 01
16 rounds on record
- 02
Mostly Series B and Series A: 64% of its rounds
- 03
Sole investor in 1 rounds, median $700M
- 04
3 exits from the portfolio
What they do
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Financial ServicesMedical DeviceBiopharma
- Based in
- Cambridge, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first16 appearances
- 2015
5 rounds
- Sept
- Sept
- Aug
- Jun
- Feb
- 2014
3 rounds
- Oct
- May
- Jan
- 2011
1 round
- May
- 2010
1 round
- Mar
- 2009
1 round
- Dec
- 2008
3 rounds
- Dec
- Sept
- Aug
- 2007
1 round
- Dec
- 2006
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
bluebird bioListed$101MJun 2013
KaloBios PharmaceuticalsListedUndisclosedJan 2013
Sirtris PharmaceuticalsBought by GlaxoSmithKline$720MApr 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
VerigenUndisclosedFeb 2005
PeptimmuneUndisclosedJul 1999